
uniQure Securities Class Action Seeks Investors Over FDA Approval Claims
uniQure faces securities class action lawsuit over allegedly false FDA approval statements. Investors who purchased stock between September-October 2025 can join the case by April 2026.
QUREsecurities fraudclass action lawsuit




